Display options
Cite
Jasul G, Paz-Pacheco E, Jimeno C, et al. AFES A.S.-O.N.E.: ASEAN Survey Of Needs in Endocrinology in the Time of the COVID-19 Pandemic. J ASEAN Fed Endocr Soc. 2020;35(1):5-13doi: 10.15605/jafes.035.01.10.
Jasul, G., Paz-Pacheco, E., Jimeno, C., Suastika, K., Hussein, Z., Mustafa, N., Aung, A. A., Robles, J., Leow, M. K. S., Deerochanawong, C., Khue, N. T., & Dang, T. H. (2020). AFES A.S.-O.N.E.: ASEAN Survey Of Needs in Endocrinology in the Time of the COVID-19 Pandemic. Journal of the ASEAN Federation of Endocrine Societies, 35(1), 5-13. https://doi.org/10.15605/jafes.035.01.10
Jasul, Gabriel, et al. "AFES A.S.-O.N.E.: ASEAN Survey Of Needs in Endocrinology in the Time of the COVID-19 Pandemic." Journal of the ASEAN Federation of Endocrine Societies vol. 35,1 (2020): 5-13. doi: https://doi.org/10.15605/jafes.035.01.10
Jasul G, Paz-Pacheco E, Jimeno C, Suastika K, Hussein Z, Mustafa N, Aung AA, Robles J, Leow MKS, Deerochanawong C, Khue NT, Dang TH. AFES A.S.-O.N.E.: ASEAN Survey Of Needs in Endocrinology in the Time of the COVID-19 Pandemic. J ASEAN Fed Endocr Soc. 2020;35(1):5-13. doi: 10.15605/jafes.035.01.10. Epub 2020 May 29. PMID: 33790494; PMCID: PMC7992306.
Copy Download .nbib Format: NLM
Share it on

J ASEAN Fed Endocr Soc. 2020;35(1):5-13. doi: 10.15605/jafes.035.01.10. Epub 2020 May 29.

AFES A.S.-O.N.E.: ASEAN Survey Of Needs in Endocrinology in the Time of the COVID-19 Pandemic.

Journal of the ASEAN Federation of Endocrine Societies

Gabriel Jasul, Elizabeth Paz-Pacheco, Cecilia Jimeno, Ketut Suastika, Zanariah Hussein, Norlaila Mustafa, Aye Aye Aung, Jeremyjones Robles, Melvin Khee Shing Leow, Chaicharn Deerochanawong, Nguyen Thy Khue, Tran Huu Dang

Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, University of the Philippines College of Medicine (UPCM)-Philippine General Hospital.
  2. Diabetes, Thyroid and Endocrine Center, St. Luke's Medical Center, Quezon City, Philippines.
  3. The Medical City, Pasig City, Philippines.
  4. UPCM Department of Pharmacology and Toxicology, Manila, Philippines.
  5. Indonesian Society of Endocrinology (ISE).
  6. Malaysian Endocrine and Metabolic Society (MEMS).
  7. Myanmar Society of Endocrinology and Metabolism (MSEM).
  8. Philippine Society of Endocrinology, Diabetes and Metabolism (PSEDM).
  9. Endocrine and Metabolic Society of Singapore (EMSS).
  10. Endocrine Society of Thailand (EST).
  11. Vietnam Association of Diabetes and Endocrinology (VADE).

PMID: 33790494 PMCID: PMC7992306 DOI: 10.15605/jafes.035.01.10

Abstract

OBJECTIVES: The COVID-19 pandemic has made a major impact on hospital services globally, including the care of persons with diabetes and endocrine disorders. The aim of this study is to describe the epidemiology of COVID-19 in the ASEAN Federation of Endocrine Societies (AFES) member countries; to describe challenges, changes and opportunities in caring for patients with endocrine diseases, as well as in fellowship training programs, and endocrinerelated research in the AFES countries.

METHODOLOGY: The

RESULTS: The burden of COVID-19 cases varied widely across the AFES member countries, with the least number of cases in Vietnam and Myanmar, and the greatest number of cases in either the most populous countries (Indonesia and the Philippines), or a country with the highest capability for testing (Singapore). The case fatality rate was also the highest for Indonesia and the Philippines at around 6%, and lowest for Vietnam at no fatalities. The percentage with diabetes among patients with COVID-19 ranged from 5% in Indonesia to 20% in Singapore, approximating the reported percentages in China and the United States. The major challenges in managing patients with endocrine diseases involved inaccessibility of health care providers, clinics and hospitals due to the implementation of lockdowns, community quarantines or movement control among the member countries. This led to disruptions in the continuity of care, testing and monitoring, and for some, provision of both preventive care and active management including surgery for thyroid cancer or pituitary and adrenal tumors, and radioactive iodine therapy. Major disruptions in the endocrine fellowship training programs were also noted across the region, so that some countries have had to freeze hiring of new trainees or to revise both program requirements and approaches to training due to the closure of outpatient endocrine clinics. The same observations are seen for endocrine-related researches, as most research papers have focused on the pandemic. Finally, the report ends by describing innovative approaches to fill in the gap in training and in improving patient access to endocrine services by Telemedicine.

CONCLUSION: The burden of COVID-19 cases and its case fatality rate varies across the AFES member countries but its impact is almost uniform: it has disrupted the provision of care for patients with endocrine diseases, and has also disrupted endocrine fellowship training and endocrine-related research across the region. Telemedicine and innovations in training have been operationalized across the AFES countries in an attempt to cope with the disruptions from COVID-19, but its over-all impact on the practice of endocrinology across the region will only become apparent once we conquer this pandemic.

© 2020 Journal of the ASEAN Federation of Endocrine Societies.

Keywords: COVID-19; SARS-CoV-2; Southeast Asia; endocrine care; survey

References

  1. J Clin Endocrinol Metab. 2020 May 1;105(5): - PubMed
  2. J ASEAN Fed Endocr Soc. 2020;35(1):49-51 - PubMed
  3. World J Diabetes. 2012 Jun 15;3(6):110-7 - PubMed
  4. Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741 - PubMed
  5. Clin Endocrinol (Oxf). 2005 Aug;63(2):197-202 - PubMed
  6. J ASEAN Fed Endocr Soc. 2020;35(1):52-54 - PubMed
  7. J Endocrinol Invest. 2020 Jul;43(7):1027-1031 - PubMed
  8. Endocrine. 2020 Apr;68(1):2-5 - PubMed
  9. Infect Dis Poverty. 2020 Apr 28;9(1):45 - PubMed
  10. J ASEAN Fed Endocr Soc. 2020;35(1):55-57 - PubMed
  11. Obes Surg. 2020 Jun;30(6):2071-2073 - PubMed
  12. Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550 - PubMed
  13. J ASEAN Fed Endocr Soc. 2020;35(1):29-32 - PubMed
  14. Andrology. 2020 May;8(3):528-529 - PubMed
  15. Diabetes Care. 2020 Aug;43(8):e81-e82 - PubMed
  16. J ASEAN Fed Endocr Soc. 2020;35(1):14-25 - PubMed
  17. Diabetes Metab Syndr. 2020 May - Jun;14(3):211-212 - PubMed
  18. Diabetes Res Clin Pract. 2020 Apr;162:108142 - PubMed
  19. MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386 - PubMed
  20. Endocrine. 2020 Apr;68(1):1 - PubMed
  21. J Diabetes. 2020 Apr;12(4):347-348 - PubMed
  22. J Clin Endocrinol Metab. 2020 Jul 1;105(7): - PubMed
  23. Diabetes Metab Syndr Obes. 2019 Mar 04;12:291-298 - PubMed

Publication Types